Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 265 to 275 of 275 entries
Sorted by: Best Match Show Resources per page
GENERAL DISCUSSION.

Annals of the New York Academy of Sciences

Benson AA.
PMID: 29090749
Ann N Y Acad Sci. 1972 Jun;195(1):173-178. doi: 10.1111/j.1749-6632.1972.tb54797.x.

No abstract available.

Cite
Benson AA. GENERAL DISCUSSION. Ann N Y Acad Sci. 1972;195(1):173-178doi: 10.1111/j.1749-6632.1972.tb54797.x.
Benson, A. A. (1972). GENERAL DISCUSSION. Annals of the New York Academy of Sciences, 195(1), 173-178. https://doi.org/10.1111/j.1749-6632.1972.tb54797.x
Benson, Andrew A. "GENERAL DISCUSSION." Annals of the New York Academy of Sciences vol. 195,1 (1972): 173-178. doi: https://doi.org/10.1111/j.1749-6632.1972.tb54797.x
Benson AA. GENERAL DISCUSSION. Ann N Y Acad Sci. 1972 Jun;195(1):173-178. doi: 10.1111/j.1749-6632.1972.tb54797.x. PMID: 29090749.
Copy Download .nbib Format: NLM
A Review on Electric and Fuel Cell Vehicle Anatomy, Technology Evolution and Policy Drivers towards EVs and FCEVs Market Propagation.

Chemical record (New York, N.Y.)

Chandran M, Palanisamy K, Benson D, Sundaram S.
PMID: 34796621
Chem Rec. 2021 Nov 19; doi: 10.1002/tcr.202100235. Epub 2021 Nov 19.

The transportation sector is the largest consumer of fossil fuels; making it a major producer of greenhouse gases. Due to declining fossil fuel reserves and increasingly stringent vehicle emission regulations globally, it is essential to shift to alternative energy...

Cite
Chandran M, Palanisamy K, Benson D, et al. A Review on Electric and Fuel Cell Vehicle Anatomy, Technology Evolution and Policy Drivers towards EVs and FCEVs Market Propagation. Chem Rec. 2021;doi: 10.1002/tcr.202100235.
Chandran, M., Palanisamy, K., Benson, D., & Sundaram, S. (2021). A Review on Electric and Fuel Cell Vehicle Anatomy, Technology Evolution and Policy Drivers towards EVs and FCEVs Market Propagation. Chemical record (New York, N.Y.), . https://doi.org/10.1002/tcr.202100235
Chandran, Mathan, et al. "A Review on Electric and Fuel Cell Vehicle Anatomy, Technology Evolution and Policy Drivers towards EVs and FCEVs Market Propagation." Chemical record (New York, N.Y.) vol. (2021). doi: https://doi.org/10.1002/tcr.202100235
Chandran M, Palanisamy K, Benson D, Sundaram S. A Review on Electric and Fuel Cell Vehicle Anatomy, Technology Evolution and Policy Drivers towards EVs and FCEVs Market Propagation. Chem Rec. 2021 Nov 19; doi: 10.1002/tcr.202100235. Epub 2021 Nov 19. PMID: 34796621.
Copy Download .nbib Format: NLM
Accomplishments in 2007 in the management of localized pancreatic cancer.

Gastrointestinal cancer research : GCR

Benson AB, Moore M.
PMID: 19352466
Gastrointest Cancer Res. 2008 May;2(3):S32-6.

Overview of the Disease IncidencePrognostic or Predictive FactorsCurrent General Therapy StandardsAccomplishments During the Year TherapyBiomarkersBasic ScienceWhat Needs To Be Done Applications of the AccomplishmentsControversies and DisagreementsFuture Directions Comments on ResearchObstacles to Progress.

Cite
Benson AB, Moore M. Accomplishments in 2007 in the management of localized pancreatic cancer. Gastrointest Cancer Res. 2008;2(3):S32-6
Benson, A. B., & Moore, M. (2008). Accomplishments in 2007 in the management of localized pancreatic cancer. Gastrointestinal cancer research : GCR, 2(3), S32-6.
Benson, Al B, and Moore, Malcolm. "Accomplishments in 2007 in the management of localized pancreatic cancer." Gastrointestinal cancer research : GCR vol. 2,3 (2008): S32-6.
Benson AB, Moore M. Accomplishments in 2007 in the management of localized pancreatic cancer. Gastrointest Cancer Res. 2008 May;2(3):S32-6. PMID: 19352466; PMCID: PMC2664916.
Copy Download .nbib Format: NLM
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling.

Liver cancer

Kelley RK, Joseph NM, Nimeiri HS, Hwang J, Kulik LM, Ngo Z, Behr SC, Onodera C, Zhang K, Bocobo AG, Benson AB, Venook AP, Gordan JD.
PMID: 34950179
Liver Cancer. 2021 Sep 06;10(6):561-571. doi: 10.1159/000518297. eCollection 2021 Nov.

BACKGROUND: The mammalian target of rapamycin (METHODS: We conducted a single-arm, multicenter phase II trial of the combination of temsirolimus 10 mg intravenously weekly plus sorafenib 200 mg b.i.dRESULTS: Twenty-nine patients were enrolled, including 48% with hepatitis C virus...

Cite
Kelley RK, Joseph NM, Nimeiri HS, et al. Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling. Liver Cancer. 2021;10(6):561-571doi: 10.1159/000518297.
Kelley, R. K., Joseph, N. M., Nimeiri, H. S., Hwang, J., Kulik, L. M., Ngo, Z., Behr, S. C., Onodera, C., Zhang, K., Bocobo, A. G., Benson, A. B., Venook, A. P., & Gordan, J. D. (2021). Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling. Liver cancer, 10(6), 561-571. https://doi.org/10.1159/000518297
Kelley, Robin K, et al. "Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling." Liver cancer vol. 10,6 (2021): 561-571. doi: https://doi.org/10.1159/000518297
Kelley RK, Joseph NM, Nimeiri HS, Hwang J, Kulik LM, Ngo Z, Behr SC, Onodera C, Zhang K, Bocobo AG, Benson AB, Venook AP, Gordan JD. Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling. Liver Cancer. 2021 Sep 06;10(6):561-571. doi: 10.1159/000518297. eCollection 2021 Nov. PMID: 34950179; PMCID: PMC8647100.
Copy Download .nbib Format: NLM
Quantifying jumps and external load in netball using VERT inertial measurement units.

Sports biomechanics

Brooks ER, Benson AC, Fox AS, Bruce LM.
PMID: 34871143
Sports Biomech. 2021 Dec 06;1-10. doi: 10.1080/14763141.2021.2009906. Epub 2021 Dec 06.

This study assesses the relationship between an inexpensive and an established inertial measurement device for the measurement of movement and jumps in netball. Twenty-five female netballers participated in this study (11 elite and 14 sub-elite). Two inertial measurement devices...

Cite
Brooks ER, Benson AC, Fox AS, et al. Quantifying jumps and external load in netball using VERT inertial measurement units. Sports Biomech. 2021;1-10doi: 10.1080/14763141.2021.2009906.
Brooks, E. R., Benson, A. C., Fox, A. S., & Bruce, L. M. (2021). Quantifying jumps and external load in netball using VERT inertial measurement units. Sports biomechanics, 1-10. https://doi.org/10.1080/14763141.2021.2009906
Brooks, Edward R, et al. "Quantifying jumps and external load in netball using VERT inertial measurement units." Sports biomechanics vol. (2021): 1-10. doi: https://doi.org/10.1080/14763141.2021.2009906
Brooks ER, Benson AC, Fox AS, Bruce LM. Quantifying jumps and external load in netball using VERT inertial measurement units. Sports Biomech. 2021 Dec 06;1-10. doi: 10.1080/14763141.2021.2009906. Epub 2021 Dec 06. PMID: 34871143.
Copy Download .nbib Format: NLM
Common deletion variants causing protocadherin-α deficiency contribute to the complex genetics of BAV and left-sided congenital heart disease.

HGG advances

Teekakirikul P, Zhu W, Gabriel GC, Young CB, Williams K, Martin LJ, Hill JC, Richards T, Billaud M, Phillippi JA, Wang J, Wu Y, Tan T, Devine W, Lin JH, Bais AS, Klonowski J, de Bellaing AM, Saini A, Wang MX, Emerel L, Salamacha N, Wyman SK, Lee C, Sing Li H, Miron A, Zhang J, Xing J, McNamara DM, Fung E, Kirshbom P, Mahle W, Kochilas LK, He Y, Garg V, White P, McBride KL, Benson DW, Gleason TG, Mital S, Lo CW.
PMID: 34888534
HGG Adv. 2021 Jul 08;2(3). doi: 10.1016/j.xhgg.2021.100037. Epub 2021 Jul 29.

Bicuspid aortic valve (BAV) with ~1%-2% prevalence is the most common congenital heart defect (CHD). It frequently results in valve disease and aorta dilation and is a major cause of adult cardiac surgery. BAV is genetically linked to rare...

Cite
Teekakirikul P, Zhu W, Gabriel GC, et al. Common deletion variants causing protocadherin-α deficiency contribute to the complex genetics of BAV and left-sided congenital heart disease. HGG Adv. 2021;2(3)doi: 10.1016/j.xhgg.2021.100037.
Teekakirikul, P., Zhu, W., Gabriel, G. C., Young, C. B., Williams, K., Martin, L. J., Hill, J. C., Richards, T., Billaud, M., Phillippi, J. A., Wang, J., Wu, Y., Tan, T., Devine, W., Lin, J. H., Bais, A. S., Klonowski, J., de Bellaing, A. M., Saini, A., Wang, M. X., Emerel, L., Salamacha, N., Wyman, S. K., Lee, C., Sing Li, H., Miron, A., Zhang, J., Xing, J., McNamara, D. M., Fung, E., Kirshbom, P., Mahle, W., Kochilas, L. K., He, Y., Garg, V., White, P., McBride, K. L., Benson, D. W., Gleason, T. G., Mital, S., & Lo, C. W. (2021). Common deletion variants causing protocadherin-α deficiency contribute to the complex genetics of BAV and left-sided congenital heart disease. HGG advances, 2(3), . https://doi.org/10.1016/j.xhgg.2021.100037
Teekakirikul, Polakit, et al. "Common deletion variants causing protocadherin-α deficiency contribute to the complex genetics of BAV and left-sided congenital heart disease." HGG advances vol. 2,3 (2021). doi: https://doi.org/10.1016/j.xhgg.2021.100037
Teekakirikul P, Zhu W, Gabriel GC, Young CB, Williams K, Martin LJ, Hill JC, Richards T, Billaud M, Phillippi JA, Wang J, Wu Y, Tan T, Devine W, Lin JH, Bais AS, Klonowski J, de Bellaing AM, Saini A, Wang MX, Emerel L, Salamacha N, Wyman SK, Lee C, Sing Li H, Miron A, Zhang J, Xing J, McNamara DM, Fung E, Kirshbom P, Mahle W, Kochilas LK, He Y, Garg V, White P, McBride KL, Benson DW, Gleason TG, Mital S, Lo CW. Common deletion variants causing protocadherin-α deficiency contribute to the complex genetics of BAV and left-sided congenital heart disease. HGG Adv. 2021 Jul 08;2(3). doi: 10.1016/j.xhgg.2021.100037. Epub 2021 Jul 29. PMID: 34888534; PMCID: PMC8653519.
Copy Download .nbib Format: NLM
Conversation with Dale Bredesen, MD.

Integrative medicine (Encinitas, Calif.)

Benson D.
PMID: 34803540
Integr Med (Encinitas). 2021 Oct;20(5):44-47.

No abstract available.

Cite
Benson D. Conversation with Dale Bredesen, MD. Integr Med (Encinitas). 2021;20(5):44-47
Benson, D. (2021). Conversation with Dale Bredesen, MD. Integrative medicine (Encinitas, Calif.), 20(5), 44-47.
Benson, Dick. "Conversation with Dale Bredesen, MD." Integrative medicine (Encinitas, Calif.) vol. 20,5 (2021): 44-47.
Benson D. Conversation with Dale Bredesen, MD. Integr Med (Encinitas). 2021 Oct;20(5):44-47. PMID: 34803540; PMCID: PMC8594968.
Copy Download .nbib Format: NLM
Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT).

Archives of hematology and blood diseases

Pandit A, Wei L, Bustamante L, Elder P, Falk WBS, Sell M, Rosko A, Benson DM, Devine SM, Hofmeister CC, Efebera YA.
PMID: 35005626
Arch Hematol Blood Dis. 2019;2(1):12-18.

To date, there is no standard of care for patients with newly diagnosed Primary (AL) amyloidosis. Autologous hematopoietic stem cell transplant (aHSCT) is a reasonable option, but has been limited in its use due to increase in treatment-related mortality...

Cite
Pandit A, Wei L, Bustamante L, et al. Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT). Arch Hematol Blood Dis. 2019;2(1):12-18
Pandit, A., Wei, L., Bustamante, L., Elder, P., Falk, W. B. S., Sell, M., Rosko, A., Benson, D. M., Devine, S. M., Hofmeister, C. C., & Efebera, Y. A. (2019). Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT). Archives of hematology and blood diseases, 2(1), 12-18.
Pandit, Akshata, et al. "Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT)." Archives of hematology and blood diseases vol. 2,1 (2019): 12-18.
Pandit A, Wei L, Bustamante L, Elder P, Falk WBS, Sell M, Rosko A, Benson DM, Devine SM, Hofmeister CC, Efebera YA. Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT). Arch Hematol Blood Dis. 2019;2(1):12-18. PMID: 35005626; PMCID: PMC8734359.
Copy Download .nbib Format: NLM
Exploring Factors of Mobile Device Adoption in Nursing Education.

Computers, informatics, nursing : CIN

Forehand JW, Benson AD, Chance KD, Armstrong B.
PMID: 33901046
Comput Inform Nurs. 2021 Apr 26;39(9):477-483. doi: 10.1097/CIN.0000000000000751.

The world has seen an explosion in mobile device technology over the past decade, in addition to the impact that COVID-19 has placed on nursing education programs. More specifically, mobile devices have afforded users with endless possibilities. This upsurge...

Cite
Forehand JW, Benson AD, Chance KD, et al. Exploring Factors of Mobile Device Adoption in Nursing Education. Comput Inform Nurs. 2021;39(9):477-483doi: 10.1097/CIN.0000000000000751.
Forehand, J. W., Benson, A. D., Chance, K. D., & Armstrong, B. (2021). Exploring Factors of Mobile Device Adoption in Nursing Education. Computers, informatics, nursing : CIN, 39(9), 477-483. https://doi.org/10.1097/CIN.0000000000000751
Forehand, Jeffery W, et al. "Exploring Factors of Mobile Device Adoption in Nursing Education." Computers, informatics, nursing : CIN vol. 39,9 (2021): 477-483. doi: https://doi.org/10.1097/CIN.0000000000000751
Forehand JW, Benson AD, Chance KD, Armstrong B. Exploring Factors of Mobile Device Adoption in Nursing Education. Comput Inform Nurs. 2021 Apr 26;39(9):477-483. doi: 10.1097/CIN.0000000000000751. PMID: 33901046.
Copy Download .nbib Format: NLM
Correction: Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease.

PLoS genetics

Audain E, Wilsdon A, Breckpot J, Izarzugaza JMG, Fitzgerald TW, Kahlert AK, Sifrim A, Wünnemann F, Perez-Riverol Y, Abdul-Khaliq H, Bak M, Bassett AS, Benson DW, Berger F, Daehnert I, Devriendt K, Dittrich S, Daubeney PE, Garg V, Hackmann K, Hoff K, Hofmann P, Dombrowsky G, Pickardt T, Bauer U, Keavney BD, Klaassen S, Kramer HH, Marshall CR, Milewicz DM, Lemaire S, Coselli JS, Mitchell ME, Tomita-Mitchell A, Prakash SK, Stamm K, Stewart AFR, Silversides CK, Siebert R, Stiller B, Rosenfeld JA, Vater I, Postma AV, Caliebe A, Brook JD, Andelfinger G, Hurles ME, Thienpont B, Larsen LA, Hitz MP.
PMID: 34547032
PLoS Genet. 2021 Sep 21;17(9):e1009809. doi: 10.1371/journal.pgen.1009809. eCollection 2021 Sep.

[This corrects the article DOI: 10.1371/journal.pgen.1009679.].

Cite
Audain E, Wilsdon A, Breckpot J, et al. Correction: Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease. PLoS Genet. 2021;17(9):e1009809doi: 10.1371/journal.pgen.1009809.
Audain, E., Wilsdon, A., Breckpot, J., Izarzugaza, J. M. G., Fitzgerald, T. W., Kahlert, A. K., Sifrim, A., Wünnemann, F., Perez-Riverol, Y., Abdul-Khaliq, H., Bak, M., Bassett, A. S., Benson, D. W., Berger, F., Daehnert, I., Devriendt, K., Dittrich, S., Daubeney, P. E., Garg, V., Hackmann, K., Hoff, K., Hofmann, P., Dombrowsky, G., Pickardt, T., Bauer, U., Keavney, B. D., Klaassen, S., Kramer, H. H., Marshall, C. R., Milewicz, D. M., Lemaire, S., Coselli, J. S., Mitchell, M. E., Tomita-Mitchell, A., Prakash, S. K., Stamm, K., Stewart, A. F. R., Silversides, C. K., Siebert, R., Stiller, B., Rosenfeld, J. A., Vater, I., Postma, A. V., Caliebe, A., Brook, J. D., Andelfinger, G., Hurles, M. E., Thienpont, B., Larsen, L. A., & Hitz, M. P. (2021). Correction: Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease. PLoS genetics, 17(9), e1009809. https://doi.org/10.1371/journal.pgen.1009809
Audain, Enrique, et al. "Correction: Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease." PLoS genetics vol. 17,9 (2021): e1009809. doi: https://doi.org/10.1371/journal.pgen.1009809
Audain E, Wilsdon A, Breckpot J, Izarzugaza JMG, Fitzgerald TW, Kahlert AK, Sifrim A, Wünnemann F, Perez-Riverol Y, Abdul-Khaliq H, Bak M, Bassett AS, Benson DW, Berger F, Daehnert I, Devriendt K, Dittrich S, Daubeney PE, Garg V, Hackmann K, Hoff K, Hofmann P, Dombrowsky G, Pickardt T, Bauer U, Keavney BD, Klaassen S, Kramer HH, Marshall CR, Milewicz DM, Lemaire S, Coselli JS, Mitchell ME, Tomita-Mitchell A, Prakash SK, Stamm K, Stewart AFR, Silversides CK, Siebert R, Stiller B, Rosenfeld JA, Vater I, Postma AV, Caliebe A, Brook JD, Andelfinger G, Hurles ME, Thienpont B, Larsen LA, Hitz MP. Correction: Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease. PLoS Genet. 2021 Sep 21;17(9):e1009809. doi: 10.1371/journal.pgen.1009809. eCollection 2021 Sep. PMID: 34547032; PMCID: PMC8454942.
Copy Download .nbib Format: NLM
Meeting Patients Where They Are: Policy Platform for Telehealth and Cancer Care Delivery.

Journal of the National Comprehensive Cancer Network : JNCCN

Kircher S, Braccio N, Gallagher K, Carlos R, Wagner L, Smith ML, Balch A, Benson AB.
PMID: 34902826
J Natl Compr Canc Netw. 2021 Dec;19(12):1470-1474. doi: 10.6004/jnccn.2021.7111.

No abstract available.

Cite
Kircher S, Braccio N, Gallagher K, et al. Meeting Patients Where They Are: Policy Platform for Telehealth and Cancer Care Delivery. J Natl Compr Canc Netw. 2021;19(12):1470-1474doi: 10.6004/jnccn.2021.7111.
Kircher, S., Braccio, N., Gallagher, K., Carlos, R., Wagner, L., Smith, M. L., Balch, A., & Benson, A. B. (2021). Meeting Patients Where They Are: Policy Platform for Telehealth and Cancer Care Delivery. Journal of the National Comprehensive Cancer Network : JNCCN, 19(12), 1470-1474. https://doi.org/10.6004/jnccn.2021.7111
Kircher, Sheetal, et al. "Meeting Patients Where They Are: Policy Platform for Telehealth and Cancer Care Delivery." Journal of the National Comprehensive Cancer Network : JNCCN vol. 19,12 (2021): 1470-1474. doi: https://doi.org/10.6004/jnccn.2021.7111
Kircher S, Braccio N, Gallagher K, Carlos R, Wagner L, Smith ML, Balch A, Benson AB. Meeting Patients Where They Are: Policy Platform for Telehealth and Cancer Care Delivery. J Natl Compr Canc Netw. 2021 Dec;19(12):1470-1474. doi: 10.6004/jnccn.2021.7111. PMID: 34902826.
Copy Download .nbib Format: NLM
Showing 265 to 275 of 275 entries